Literature DB >> 11494149

The expression of HMGA genes is regulated by their 3'UTR.

L Borrmann1, S Wilkening, J Bullerdiek.   

Abstract

Many benign mesenchymal tumors are characterized by chromosomal abnormalities of the regions 12q15 or 6p21.3 leading to aberrant expression of either HMGA2 (formerly HMGIC) or HMGA1 (formerly HMGIY). The proteins of both genes belong to the HMGA (formerly HMGI(Y)) family of architectural transcription factors. As a rule, aberrant HMGA transcripts found in a variety of benign tumors have intact coding regions at least for the DNA binding domains with a truncation of their 3' untranslated regions. Adding this to the finding that an altered HMGA protein level is not always correlated with an increased amount of corresponding mRNA indicates a posttranscriptional expression control mediated by regulatory elements within the 3'UTR. To check if HMGA expression is under control of such elements we performed luciferase assays with several HMGA2 and HMGA1 3'UTRs of different length. Experiments showed that an up to 12-fold increase in luciferase activity is obtained by the truncation of the 3'UTRs suggesting that the expression of HMGA2 and HMGA1 is controlled by negatively acting regulatory elements within their 3'UTR. Chromosomal aberrations affecting the HMGA genes may therefore influence their expression by an altered stability of the truncated transcripts as a result of the cytogenetic aberrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494149     DOI: 10.1038/sj.onc.1204577

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  A single nucleotide polymorphism in 3'-untranslated region contributes to the regulation of Toll-like receptor 4 translation.

Authors:  Kayo Sato; Atsutoshi Yoshimura; Takashi Kaneko; Takashi Ukai; Yukio Ozaki; Hirotaka Nakamura; Xinyue Li; Hiroyoshi Matsumura; Yoshitaka Hara; Yorimasa Ogata
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.

Authors:  Eusebio Chiefari; Stefania Iiritano; Francesco Paonessa; Ilaria Le Pera; Biagio Arcidiacono; Mirella Filocamo; Daniela Foti; Stephen A Liebhaber; Antonio Brunetti
Journal:  Nat Commun       Date:  2010-07-27       Impact factor: 14.919

3.  Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Norimitsu Inoue; Tomohisa Izui-Sarumaru; Yoshiko Murakami; Yuichi Endo; Jun-Ichi Nishimura; Ken Kurokawa; Maki Kuwayama; Hiroaki Shime; Takashi Machii; Yuzuru Kanakura; Gabrielle Meyers; Carl Wittwer; Zhong Chen; William Babcock; Debra Frei-Lahr; Charles J Parker; Taroh Kinoshita
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

4.  Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes.

Authors:  Emmette R Hutchison; Elisa M Kawamoto; Dennis D Taub; Ashish Lal; Kotb Abdelmohsen; Yongqing Zhang; William H Wood; Elin Lehrmann; Simonetta Camandola; Kevin G Becker; Myriam Gorospe; Mark P Mattson
Journal:  Glia       Date:  2013-05-07       Impact factor: 7.452

5.  Deregulation of HMGA2 in an aggressive angiomyxoma with t(11;12)(q23;q15).

Authors:  Francesca Micci; Ioannis Panagopoulos; Bodil Bjerkehagen; Sverre Heim
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

6.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

7.  Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Authors:  Christine Mayr; Michael T Hemann; David P Bartel
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

8.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Authors:  Sugiko Watanabe; Yasuaki Ueda; Shin-ichi Akaboshi; Yuko Hino; Yoko Sekita; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

9.  Association of a high mobility group gene (HMGA2) variant with bone mineral density.

Authors:  Allison Kuipers; Yingze Zhang; Jane A Cauley; Cara S Nestlerode; Yanxia Chu; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Andrew R Hoffman; Eric S Orwoll; Joseph M Zmuda
Journal:  Bone       Date:  2009-04-17       Impact factor: 4.398

10.  Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups.

Authors:  Hammurabi Bartuma; Ioannis Panagopoulos; Anna Collin; Domenico Trombetta; Henryk A Domanski; Nils Mandahl; Fredrik Mertens
Journal:  Mol Cancer       Date:  2009-06-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.